Premium
Ovid Therapeutics Inc (OVID)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, ... Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life. Show more
A Phase 1 SAD/MAD study of OV329 is progressing as planned, and based on encouraging human safety data to date, Ovid will engage regulators about adding cohorts to increase potential dosing...
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain...
Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which has repeatedly shown to preferentially accumulate in mouse retinas, eyes...
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain...
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.34 | -24.6376811594 | 1.38 | 1.39 | 1.02 | 334064 | 1.12419458 | CS |
| 4 | -0.15 | -12.6050420168 | 1.19 | 1.47 | 1.02 | 229247 | 1.21561989 | CS |
| 12 | -0.26 | -20 | 1.3 | 1.47 | 0.96 | 164941 | 1.17558144 | CS |
| 26 | -2.11 | -66.9841269841 | 3.15 | 3.39 | 0.68 | 545329 | 0.94262079 | CS |
| 52 | -2.23 | -68.1957186544 | 3.27 | 4.1 | 0.68 | 362727 | 1.48899412 | CS |
| 156 | -2.32 | -69.0476190476 | 3.36 | 4.1389 | 0.68 | 227720 | 2.17118633 | CS |
| 260 | -1.74 | -62.5899280576 | 2.78 | 10.45 | 0.68 | 649652 | 3.87145265 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
